Nektar Therapeutics Annual Shareholders Meeting Transcript
Welcome to the 2020 Annual Meeting for Nektar Therapeutics. Our host for today's call is Mark Wilson, Senior Vice President and General Counsel. (Operator Instructions)
I will now turn the call over to your host, Mr. Wilson, you may begin, sir.
Thank you. I would like to welcome everyone to the Nektar Therapeutics' 2020 Annual Meeting of Stockholders. It is my pleasure to host the 2020 Annual Meeting, and I will serve as Chairman and Secretary of the meeting. We are excited to be hosting our first virtual meeting, which allows our stockholders to safely participate in our annual meeting.
As in past years, we will conduct the business portion of our meeting first and answer questions at the end of the meeting.
Before we begin, I would like to introduce the members of our Board of Directors who are with us today: Rob Chess, the Chairman of the Board; Jeff Ajer, Myriam Curet; Karin Eastham; R. Scott Greer; Lutz Lingnau; Howard Robin, who is also our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |